Mutual of America Capital Management LLC trimmed its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 4.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 25,690 shares of the medical research company’s stock after selling 1,059 shares during the period. Mutual of America Capital Management LLC’s holdings in IQVIA were worth $5,055,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also bought and sold shares of the company. ST Germain D J Co. Inc. acquired a new stake in IQVIA during the 2nd quarter valued at approximately $33,000. Live Oak Investment Partners acquired a new stake in IQVIA during the 4th quarter valued at approximately $41,000. MBM Wealth Consultants LLC acquired a new stake in IQVIA during the 4th quarter valued at approximately $51,000. KB Financial Partners LLC acquired a new stake in IQVIA during the 1st quarter valued at approximately $53,000. Finally, Parkside Financial Bank & Trust lifted its stake in IQVIA by 19.6% during the 2nd quarter. Parkside Financial Bank & Trust now owns 293 shares of the medical research company’s stock valued at $66,000 after acquiring an additional 48 shares during the period. 86.82% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at IQVIA
In other news, insider Kevin C. Knightly sold 13,117 shares of the company’s stock in a transaction on Friday, December 1st. The shares were sold at an average price of $214.03, for a total transaction of $2,807,431.51. Following the completion of the sale, the insider now owns 7,347 shares of the company’s stock, valued at $1,572,478.41. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 1.50% of the company’s stock.
Analyst Ratings Changes
IQVIA Price Performance
Shares of NYSE IQV opened at $217.88 on Tuesday. The firm has a market cap of $39.76 billion, a PE ratio of 36.62, a PEG ratio of 2.49 and a beta of 1.48. The firm has a fifty day moving average of $219.72 and a 200 day moving average of $211.12. The company has a debt-to-equity ratio of 2.12, a quick ratio of 0.79 and a current ratio of 0.79. IQVIA Holdings Inc. has a one year low of $167.42 and a one year high of $234.92.
IQVIA Company Profile
IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
- Five stocks we like better than IQVIA
- 3 Warren Buffett Stocks to Buy Now
- Salesforce and MongoDB: 2 must-own tech stocks
- The 3 Best Blue-Chip Stocks to Buy Now
- Udemy stock got boosted by analysts, massive growth at discounts
- What is a Special Dividend?
- 3 attractive stocks that insiders are buying
Receive News & Ratings for IQVIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQVIA and related companies with MarketBeat.com's FREE daily email newsletter.